Overview
INCI Name
COCAMIDOPROPYL BETAINE
Ingredient information based on the research currently available to us. Educational content only; not medical advice.
Cocamidopropyl betaine (CAPB) is an amphoteric surfactant used in cleansing products. Its contact-allergy literature comes largely from selected patch-test patients and does not establish population prevalence or overall cleanser mildness.
CAPB is an amphoteric surfactant used in rinse-off personal-care products. Its presence on an ingredient list tells you that it is part of the cleansing system; it does not, by itself, rank the formula's gentleness or predict whether an individual will tolerate it.[1]
A 1997 study began with only 10 people already selected because they had positive CAPB patch tests. Seven reacted during product-use testing; in follow-up testing, six of nine reacted to amidoamine and none reacted to an amidoamine-free CAPB preparation. This supports an impurity hypothesis in that small, preselected group—not a general prevalence estimate.[1]
A larger North American study tested 975 consecutive patients referred for suspected allergic contact dermatitis and compared CAPB with amidoamine reactions. Because this was a specialty patch-test population, its results cannot be translated into the percentage of all cleanser users who are allergic.[2]
The literature does not support saying that every CAPB reaction is caused by CAPB itself—or that amidoamine always explains it. Separate patch tests and clinical relevance assessment can matter, while a retail ingredient list usually does not disclose residual impurity levels.[1][3]
These are allergy and patch-test studies. They do not compare CAPB cleansers with soaps or sulfate systems for cleansing, dryness, barrier disruption, or overall tolerability. Calling a product gentle therefore requires evidence about the complete formula and its use—not merely the presence of CAPB or a sulfate-free label.[2][1]
Repeated dermatitis associated with cleansers deserves more than ingredient-list guesswork. The relevance study followed patch-positive patients specifically to determine whether test reactions matched real exposures, underscoring why clinician-directed patch testing and exposure history are more informative than self-diagnosing CAPB allergy.[4][3]
INCI Name
COCAMIDOPROPYL BETAINE